After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, RMD falls under the Healthcare sector while operating within the Medical Instruments & Supplies industry segment. The current market capitalization of Resmed Inc. is $28.33B. A total of 1.36 million shares were traded on the day, compared to an average of 899.29K shares.
In the most recent transaction, Rider Michael J sold 81 shares of RMD for 180.00 per share on Mar 04 ’24. After the transaction, the Global General Counsel now owns 6,607 company shares. In a previous transaction on Mar 01 ’24, Rider Michael J sold 200 shares at 173.25 per share. RMD shares that Global General Counsel owns now total 6,688.
Among the insiders who sold shares, FARRELL PETER C disposed of 10,935 shares on Feb 22 ’24 at a per-share price of $182.66. This resulted in the Director holding 157,404 shares of RMD after the transaction. In another insider transaction, Sandercock Brett sold 3,000 shares at $152.62 per share on Nov 27 ’23. Company shares held by the Chief Financial Officer now total 92,962.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Resmed Inc. pays an annual dividend of $1.88, resulting in a dividend yield of 0.98%, and it has a price to earnings (P/E) ratio of 31.90. RMD’s most recent ex-dividend date was 2/7/2024 when it declared a $0.48 quarterly dividend that was paid in cash on 3/14/2024. Previously, the company paid the dividend on 12/14/2023 with an ex-dividend date of 11/8/2023. The RMD stock dividend was $0.48 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, RMD has a high of $243.52 and a low of $132.24.
As of this writing, RMD has an earnings estimate of $1.9 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $1.98 per share and a lower estimate of $1.81. The company reported an EPS of $1.64 in the last quarter, which was 1.20% higher than expectations of $1.62.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $30.47, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 4.29.
